Skip to main content
Log in

Claim of superiority of SGA in the treatment of aggressiveness in schizophrenia is not supported by data

  • Letter to the Editor
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Gilles D, Sampson, S, Beck A, Rathbone J (2013) Benzodiazepines for psychosis-induced aggression or agitation. Cochrane Database Syst Rev. Issue 4. Art. No.: CD003079

  • Krakovski MI, Czobor P (2012) The denial of aggression in violent patients with schizophrenia. Schizophr Res 141:228–233

    Article  Google Scholar 

  • Swanson JW, Swartz MS, Van Dorn RA, Volavka J, Monahan J, Stroup TS, McEvoy JP, Wagner HR, Elbogen EB, Lieberman JA, CATIE investigators (2008) Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. Br J Psychiatry 193:37–43

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sophie Hirsch.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Steinert, T., Hirsch, S. Claim of superiority of SGA in the treatment of aggressiveness in schizophrenia is not supported by data. Psychopharmacology 233, 2419–2420 (2016). https://doi.org/10.1007/s00213-016-4302-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-016-4302-1

Keywords

Navigation